Amniotic Fluid Embolism
Amniotic fluid embolism is a rare, catastrophic and unpredictable obstetric emergency. It is believed to reflect an abnormal maternal immune and inflammatory response to fetal or amniotic material entering the maternal circulation. It typically occurs during labour, delivery, or the immediate postpartum period.
It produces sudden, profound cardiovascular collapse, frequently with severe coagulopathy. It is one of the leading causes of direct maternal mortality in high-resource healthcare settings.
The diagnosis is fundamentally clinical. It rests on recognising the characteristic, dramatic presentation and carefully excluding other causes of acute peripartum collapse. No specific confirmatory test is available in real time to guide immediate management.
Pathophysiology
- The precise mechanism remains incompletely understood. Contemporary understanding favours an abnormal, exaggerated maternal immune and inflammatory response to amniotic fluid or fetal cellular material entering the maternal circulation. The historical concept of simple mechanical embolic obstruction by amniotic fluid debris is now largely discredited.
- The response produces a biphasic clinical pattern. An initial phase of acute pulmonary vasospasm and right ventricular failure is followed by a phase of left ventricular dysfunction and, frequently, severe disseminated intravascular coagulation.
- The condition is genuinely unpredictable. In the great majority of cases it occurs without reliable warning signs, and no single risk factor is consistently identified.
- Some studies suggest a possible, modest association with induction of labour, advanced maternal age, and multiple pregnancy. None is a reliable predictive marker.
- It can occur during labour, at delivery (including caesarean delivery), or in the immediate postpartum period. Onset is characteristically sudden and without significant warning.













